▲ Peaking
Business
Argenx to Buy Forte Biosciences for $2.2 Billion
Argenx is expanding its immunology pipeline through a $2.2 billion acquisition of autoimmune biotech company Forte Biosciences.
Forte Biosciences
1 news trends Newsylist has tracked involving Forte Biosciences — newest first.